Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Graybug, CalciMedica sign agreement to create new biopharmaceutical company
Graybug Vision and CalciMedica have signed a definitive merger agreement to create a new clinical-stage biopharmaceutical company.
Inflammation
-
22 Nov 2022
-
19 Jan 2022
Galapagos’ Jyseleca gets UK marketing authorization for ulcerative colitis
Galapagos has obtained marketing authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Jyseleca (filgotinib 200mg tablets) to treat ulcerative colitis (UC) in Great Britain.
-
27 Jan 2021
US DOD to fund Humanetics’ new drug test against Covid-19
The US Department of Defense (DOD) has approved the funding of US-based private pharmaceutical firm Humanetics to test its drug candidate BIO 300 in treating pulmonary inflammation triggered by COVID-19.